ClinicalTrials.gg
Not yet recruitingNCT07902076Updated Oct 28, 2026

Caregiver and Child Anxiety, Relationships, and Daily Emotions ("CARE Study")

An observational study in Anxiety, sponsored by Tulane University. Not yet recruiting. Open to participants aged 9 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-28.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Tulane University · Observational

Updated Oct 28, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
280
Ages
9 Years to 12 Years
Sex
All
01

Study summary

This project will examine (a) whether parental threat communication mediates the paths from parental anxiety to children's anxiety and daily emotions, (b) whether parental threat communication mediates the link between parental anxiety and children's error monitoring in parental presence, and (c) whether children's error monitoring in parental presence is associated with anxiety, and daily emotions in real-life contexts.

Read the detailed description

Children (ages 9 to 12, to recruit 140) and their parents (140) will complete online questionnaires and participate in a lab visit. Parental threat communication will be observed during a social stress speech task. Electroencephalogram (EEG) will be recorded while children complete a Flanker task twice: in parental presence and alone. EEG data will be analyzed to compute parental modulation of children's error monitoring. Following the lab visit, children will complete a 10-day Ecological Momentary Assessment (EMA) procedure to report their daily emotions.

02

Conditions studied

  • Anxiety

Browse trials for

Keywords

  • Parental stress buffering
  • Error related negativity
  • Daily emotions
03

In context

Anxiety Disorders Unverified

7,201 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's planned enrollment of 280 is above the median of 168 across 977 observational studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Tulane University is the lead sponsor of 96 studies on the registry; 23 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 5 (56%) have results posted.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
9 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

140 children aged 9-12 (50% female) and their primary caregivers (n = 140) from New Orleans and its surrounding areas.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 9-12 (50% female) and their primary caregivers (n = 140) from New Orleans and its surrounding areas.
  • Caregiver agrees to participate in the study procedures described during the screening call (i.e., questionnaires, EEG, video-recorded behavioral tasks, and the child's completion of a 10-day ecological momentary assessment [EMA] protocol using a smartphone).
  • Speaking English fluently.

Exclusion criteria

Exclusion Criteria:

  • Severe psychopathology (e.g., schizophrenia, psychosis).
  • neurologic conditions.
  • Brain injury.
  • Hearing impairment.
  • Severe neurodevelopmental disorders (e.g., intellectual developmental disorder).
  • Active suicidality.
  • Current manic or hypomanic episode.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
280 participants (estimated)
Patient registry
No

Groups and cohorts

  • CARE study participants

    Other: EEG task with and without the parent

Interventions

  • OtherEEG task with and without the parent

    EEG will be recorded while children complete a Flanker task twice: in parental presence and alone. EEG data will be analyzed to compute parental modulation of children's error monitoring.

06

What researchers measure

Primary outcomes

  1. Child anxiety assessed via the Screen for Child Anxiety Related Emotional Disorders

    Child anxiety will be assessed via the Screen for Child Anxiety Related Emotional Disorders questionnaire. This questionnaire has 44 items. Items will be summed, with higher scores indicating greater child anxiety.

    Time frame: Baseline

  2. Error related negativity (ERN) measured by EEG

    Error-related negativity (ERN) is measured by EEG. The mean amplitude of the ERN will be calculated from a cluster of frontocentral electrodes for the first 100 milliseconds following the error responses in the incongruent trials of the Flanker task.

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07902076
Lead sponsor
Tulane University
Responsible party
Sponsor
First posted
Oct 28, 2026
Start date
Jan 3, 2027 (estimated)
Primary completion
Apr 1, 2029 (estimated)
Completion
Mar 14, 2030 (estimated)
Last update
Oct 28, 2026

Study contacts

Selin Zeytinoglu, PhD
Contact
szeytinoglu@tulane.edu
504-314-7545
Essie Diaz Perdomo, BS
Contact
ediazperdomo@tulane.edu
Selin Zeytinoglu, PhD
principal investigator · Tulane University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion